Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.78
- Piotroski Score 4.00
- Grade N/A
- Symbol (LCI)
- Company Lannett Company, Inc.
- Price $0.69
- Changes Percentage (0%)
- Change -$0
- Day Low $0.65
- Day High $0.72
- Year High $3.72
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 05/02/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$19.14
- Trailing P/E Ratio -0.035815047021944
- Forward P/E Ratio -0.035815047021944
- P/E Growth -0.035815047021944
- Net Income $-231,620,000
Income Statement
Quarterly
Annual
Latest News of LCI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Lucid's (NASDAQ:LCID) Q3 Sales Top Estimates, Stock Soars
Luxury electric car maker Lucid (LCID) met revenue expectations in Q3 2024, reporting a 45.2% sales increase to $200 million....
By Yahoo! Finance | 2 weeks ago -
Cloud banking platform nCino to buy UK regtech FullCircl
nCino, a cloud banking platform provider, has acquired UK-based FullCircl, a customer lifecycle intelligence platform, in a $135m deal. The acquisition aims to enhance data capabilities and expand cli...
By Yahoo! Finance | 3 weeks ago -
Holcim spin-off of North American business progressing "extremely well"
Holcim's CFO, Steffen Kindler, confirms that the spin-off of its North American business is on track and progressing well. The company plans to provide updates to investors soon and aims to complete t...
By Yahoo! Finance | 4 weeks ago
